Leukemia & lymphoma
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas.
Daniel Fasser, Greta Joy, Mark R Dowling, Ketan Bavishi, Andreas Kiesbye Øvlisen, Philip Choi, Stephanie P'ng, Robin Filshie, David Ritchie, Ian Bilmon, H Miles Prince, Max Wolf, Mark Hertzberg, Hun Chuah, Tarec El-Galaly
Published: 202610.1080/10428194.2025.2579721
No abstract available for this study.